Effects of moxibustion at Shenshu (BL 23) on sex hormones and AMH levels of perimenopausal women under sub-health condition
(2.The Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, China 210029)
【Abstract】Objective To compare the effects of moxibustion at Shenshu (BL 23) and oral administration of Vitamin E on life quality of perimenopausal women under sub-health condition and the relative mechanism, aiming to provide clinical evidence for the application of moxibustion to the health care of women under sub-health condition. Methods Sixty participants were randomly divided into the moxibustion group and the medication group, with 30 cases in each group. The subjects in the moxibustion group were treated with mild moxibustion at bilateral Shenshu (BL 23) for 15 minutes, once a day and five days as a course of treatment. Four continuous courses of treatment were given with an interval of two days. The subjects in the medication group were treated with oral administration of soft capsule of Vitamin E, one capsule a day for continuous 28 days. The quality of life score and serum levels of sex hormones, anti-Mullerian hormone (AMH) and inhibin B (INHB) of subjects in the two groups were measured before and after the intervention. Results ① The scores of life quality in the two groups were both increased significantly after the treatment (both P < 0.01), and the result in the moxibustion group was superior to that of the medication group (P < 0.05). ② The serum levels of estradiol (E2) and progesterone in the moxibustion group were increased remarkably after the treatment, especially for the non-menopausal subjects (both P < 0.01). ③ After moxibustion, the serum level of AMH was improved obviously (P < 0.01), but there was no statistical difference in INHB level (P > 0.05). Conclusion Moxibustion can effectively improve the life quality of perimenopausal women under sub-health condition, regulate the levels of sex hormones and AMH, improve ovarian reserve function, and delay ovarian aging.
【Keywords】 perimenopause; sub-health; acupuncture and moxibustion; sex hormone; anti-Mullerian hormone (AMH);
 Shen J, Ai BW, Shen MH. Intervention of mild moxibustion at Shenshu (BL 23) on perimenopausal women under sub-health condition [J]. Journal of Nanjing University of Traditional Chinese Medicine, 2015, 31 (6): 532–535 (in Chinese).
 Zec I, Tislaric-Medenjak D, Megla ZB, et al. AntiMüllerian hormone: a unique biochemical marker of gonadal development and fertility in humans [J]. Biochem Med (Zagreb), 2011, 21 (3): 219–230.
 Liu BY, He LY, Xie YM, et al. Development of the questionnaire on the basic syndrome characteristics of Chinese medicine of sub-health status [J]. Chinese Journal of Basic Medicine In Traditional Chinese Medicine, 2004, 10 (9): 23–28 (in Chinese).
 Hao YT, Fang JQ. The Chinese version of The World Health Organization Quality of Life Scale and its instructions [J]. Modern Rehabilitation, 2000, 4 (8): 1127–1129 (in Chinese).
 XU Y, MA XP, DING J, et al. Treatment with qibaomeiran, a kidney-invigorating Chinese herbal formula, antagonizes estrogen decline in ovariectomized rats [J]. Rejuvenation Res, 2014, 17 (4): 372–381.
 Li XH, Xie JP, Zhang LF, et al. Experimental study on the influence of routine moxibustion on uterine tissue morphology and E2, P and ER-α in natural menopausal rats [J]. Journal of Beijing University of Traditional Chinese Medicine, 2006, 29 (8): 558–561 (in Chinese).
 Kong YK, Geng XQ, Yin JJ, et al. Effects of Vitamin E on the expression of estrogen and hippocampal aromatase in elderly female rats [J]. Chinese Journal of Gerontology, 2009, 29 (9): 1058–1060 (in Chinese).
 Lu CZ, Shi YH, Jiao RS, et al. Discussion on the mechanism of protective effects of Vitamin E on the ovarian granule cells in elderly rats [J]. Chinese Journal of Applied Physiology, 2009, 25 (4): 565–568 (in Chinese).
 Christopher E, Ken L. Estrogen cause dynamic alternations in endothelial estrogen receptor expression [J]. Circ Res, 2002, 91 (9): 814–820.
 Ao F, Shen Y, Wu Y, et al. Effects of estrogen on the expression of estrogen receptor α in vascular smooth muscle cells of adult and elderly female rats and their mechanism [J]. Chin J Histochem Cytochem, 2014, 23 (6): 481–485 (in Chinese).
 Freeman EW, Sammel MD, Lin H, et al. Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women [J]. J Clin Endocrinol Metab, 2012, 97 (5): 1673–1680.
 Josso N, Clemente N. Transduction pathway of antiMüllerian hormone, a sex-specific member of the TGF-β family [J]. Trends Endocrinol Metab, 2003, 14 (2): 91–97.
 Budi W, Mila M, Priangga MD, et al. Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients [J]. J Assist Reprod Genet, 2014, 31 (10): 1311–1316.
 Appt SE, Clarkson TB, Chen H, et al. Serum antimüllerian hormone predicts ovarian reserve in a monkey model [J]. Menopause, 2009, 16 (3): 597–601.
 Li HW, Lee VC, Lau EY, et al. Ovarian response and cumulative live birth rate of women undergoing in-vitro fertilisation who had discordant anti-mullerian hormone and antral follicle count measurements:a retrospective study [J]. PloS One, 2014, 9 (10): e108493.
 Holte A, Brodin T, Berglund L, et al. Antral follicle counts are strongly associated with live-birth rates after assisted reproduction with superior treatment outcome in women with polycystic ovaries [J]. Fertil Steril, 2011, 96 (3): 594–599.
 Burger HG, Hale GE, Robertson DM, et al. A review of hormonal changes during the menopausal transition: focus on findings from the Melbourne Women’s Midlife Health Project [J]. Hum Reprod Update, 2007, 13 (6): 559–565.
 Su HI, Sammel MD, Homer MA, et al. Comparability of antimüllerian hormone levels among commercially available immunoassays [J]. Fertil Steril, 2014, 101 (6): 1766–1772.